Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 337

1.

Bread enriched with phytosterols with or without curcumin modulates lipoprotein profiles in hypercholesterolaemic individuals. A randomised controlled trial.

Ferguson JJA, Wolska A, Remaley AT, Stojanovski E, MacDonald-Wicks L, Garg ML.

Food Funct. 2019 Apr 16. doi: 10.1039/c8fo02512f. [Epub ahead of print]

PMID:
30990213
2.

Proteomic alterations of HDL in youth with type 1 diabetes and their associations with glycemic control: a case-control study.

Gourgari E, Ma J, Playford MP, Mehta NN, Goldman R, Remaley AT, Gordon SM.

Cardiovasc Diabetol. 2019 Mar 28;18(1):43. doi: 10.1186/s12933-019-0846-9.

3.

Dietary Palmitoleic Acid Attenuates Atherosclerosis Progression and Hyperlipidemia in Low-Density Lipoprotein Receptor-Deficient Mice.

Yang ZH, Pryor M, Noguchi A, Sampson M, Johnson B, Pryor M, Donkor K, Amar M, Remaley AT.

Mol Nutr Food Res. 2019 Mar 28:e1900120. doi: 10.1002/mnfr.201900120. [Epub ahead of print]

PMID:
30921498
4.

Apolipoprotein C-II Mimetic Peptide Promotes the Plasma Clearance of Triglyceride-Rich Lipid Emulsion and the Incorporation of Fatty Acids into Peripheral Tissues of Mice.

Komatsu T, Sakurai T, Wolska A, Amar MJ, Sakurai A, Vaisman BL, Sviridov D, Demosky S, Pryor M, Ikewaki K, Remaley AT.

J Nutr Metab. 2019 Feb 3;2019:7078241. doi: 10.1155/2019/7078241. eCollection 2019.

5.

DENND5B Regulates Intestinal Triglyceride Absorption and Body Mass.

Gordon SM, Neufeld EB, Yang Z, Pryor M, Freeman LA, Fan X, Kullo IJ, Biesecker LG, Remaley AT.

Sci Rep. 2019 Mar 5;9(1):3597. doi: 10.1038/s41598-019-40296-0.

6.

Where There Is Smoke, There Is Fire.

Wolska A, Levine SJ, Remaley AT.

Arterioscler Thromb Vasc Biol. 2019 Mar;39(3):306-308. doi: 10.1161/ATVBAHA.119.312398. No abstract available.

PMID:
30811249
7.

Plasma Lipoprotein-X Quantification on Filipin-Stained Gels: Monitoring Recombinant LCAT Treatment Ex-Vivo.

Freeman LA, Shamburek RD, Sampson ML, Neufeld EB, Sato M, Karathanasis SK, Remaley AT.

J Lipid Res. 2019 Feb 26. pii: jlr.D090233. doi: 10.1194/jlr.D090233. [Epub ahead of print]

8.

High-density lipoprotein lifts the "dark web" cast by neutrophils.

Lucero D, Neufeld EB, Remaley AT.

Ann Transl Med. 2018 Nov;6(Suppl 1):S24. doi: 10.21037/atm.2018.09.28. No abstract available.

9.

Association Between Oxidation-Modified Lipoproteins and Coronary Plaque in Psoriasis.

Sorokin AV, Kotani K, Elnabawi YA, Dey AK, Sajja AP, Yamada S, Ueda M, Harrington CL, Baumer Y, Rodante JA, Gelfand JM, Chen MY, Joshi AA, Playford MP, Remaley AT, Mehta NN.

Circ Res. 2018 Nov 9;123(11):1244-1254. doi: 10.1161/CIRCRESAHA.118.313608.

PMID:
30571459
10.

Low cholesterol efflux capacity and abnormal lipoprotein particles in youth with type 1 diabetes: a case control study.

Gourgari E, Playford MP, Campia U, Dey AK, Cogen F, Gubb-Weiser S, Mete M, Desale S, Sampson M, Taylor A, Rother KI, Remaley AT, Mehta NN.

Cardiovasc Diabetol. 2018 Dec 19;17(1):158. doi: 10.1186/s12933-018-0802-0.

11.

LCAT Enzyme Replacement Therapy Reduces LpX and Improves Kidney Function in a Mouse Model of Familial LCAT Deficiency.

Vaisman BL, Neufeld EB, Freeman LA, Gordon SM, Sampson ML, Pryor M, Hillman E, Axley MJ, Karathanasis SK, Remaley AT.

J Pharmacol Exp Ther. 2019 Mar;368(3):423-434. doi: 10.1124/jpet.118.251876. Epub 2018 Dec 18.

12.

Molecular basis for activation of lecithin:cholesterol acyltransferase by a compound that increases HDL cholesterol.

Manthei KA, Yang SM, Baljinnyam B, Chang L, Glukhova A, Yuan W, Freeman LA, Maloney DJ, Schwendeman A, Remaley AT, Jadhav A, Tesmer JJ.

Elife. 2018 Nov 27;7. pii: e41604. doi: 10.7554/eLife.41604.

13.

Reconstituted Discoidal High-Density Lipoproteins: Bioinspired Nanodiscs with Many Unexpected Applications.

Tsujita M, Wolska A, Gutmann DAP, Remaley AT.

Curr Atheroscler Rep. 2018 Nov 5;20(12):59. doi: 10.1007/s11883-018-0759-1. Review.

PMID:
30397748
14.

Intravenous toxicity and toxicokinetics of an HDL mimetic, Fx-5A peptide complex, in cynomolgus monkeys.

Bourdi M, Amar M, Remaley AT, Terse PS.

Regul Toxicol Pharmacol. 2018 Dec;100:59-67. doi: 10.1016/j.yrtph.2018.10.009. Epub 2018 Oct 22.

PMID:
30359697
15.

Is Low-Density Lipoprotein Cholesterol the Key to Interpret the Role of Lecithin:Cholesterol Acyltransferase in Atherosclerosis?

Vitali C, Remaley AT, Cuchel M.

Circulation. 2018 Sep 4;138(10):1008-1011. doi: 10.1161/CIRCULATIONAHA.118.035358. No abstract available.

PMID:
30354544
16.

High density lipoprotein proteome is associated with cardiovascular risk factors and atherosclerosis burden as evaluated by coronary CT angiography.

Gordon SM, Chung JH, Playford MP, Dey AK, Sviridov D, Seifuddin F, Chen YC, Pirooznia M, Chen MY, Mehta NN, Remaley AT.

Atherosclerosis. 2018 Nov;278:278-285. doi: 10.1016/j.atherosclerosis.2018.09.032. Epub 2018 Sep 25.

PMID:
30347343
17.

Coexpression of novel furin-resistant LPL variants with lipase maturation factor 1 enhances LPL secretion and activity.

Wu MJ, Wolska A, Roberts BS, Pearson EM, Gutgsell AR, Remaley AT, Neher SB.

J Lipid Res. 2018 Dec;59(12):2456-2465. doi: 10.1194/jlr.D086793. Epub 2018 Oct 14.

PMID:
30318473
18.

GlycA is not a useful biomarker of inflammation in sickle cell disease.

Weisman JK, Meeks D, Mendelsohn L, Remaley AT, Sampson M, Allen DT, Nichols J, Shet AS, Thein SL.

Int J Lab Hematol. 2018 Dec;40(6):704-709. doi: 10.1111/ijlh.12907. Epub 2018 Aug 27.

19.

Myeloid-Specific Deletion of Peptidylarginine Deiminase 4 Mitigates Atherosclerosis.

Liu Y, Carmona-Rivera C, Moore E, Seto NL, Knight JS, Pryor M, Yang ZH, Hemmers S, Remaley AT, Mowen KA, Kaplan MJ.

Front Immunol. 2018 Jul 26;9:1680. doi: 10.3389/fimmu.2018.01680. eCollection 2018.

20.

Evaluation of Recipients of Positive and Negative Secondary Findings Evaluations in a Hybrid CLIA-Research Sequencing Pilot.

Sapp JC, Johnston JJ, Driscoll K, Heidlebaugh AR, Miren Sagardia A, Dogbe DN, Umstead KL, Turbitt E, Alevizos I, Baron J, Bönnemann C, Brooks B, Donkervoort S, Jee YH, Linehan WM, McMahon FJ, Moss J, Mullikin JC, Nielsen D, Pelayo E, Remaley AT, Siegel R, Su H, Zarate C; NISC Comparative Sequencing Program, Manolio TA, Biesecker BB, Biesecker LG.

Am J Hum Genet. 2018 Sep 6;103(3):358-366. doi: 10.1016/j.ajhg.2018.07.018. Epub 2018 Aug 16.

21.

Comparability of Lipoprotein Particle Number Concentrations Across ES-DMA, NMR, LC-MS/MS, Immunonephelometry, and VAP: In Search of a Candidate Reference Measurement Procedure for apoB and non-HDL-P Standardization.

Delatour V, Clouet-Foraison N, Gaie-Levrel F, Marcovina SM, Hoofnagle AN, Kuklenyik Z, Caulfield MP, Otvos JD, Krauss RM, Kulkarni KR, Contois JH, Remaley AT, Vesper HW, Cobbaert CM, Gillery P.

Clin Chem. 2018 Oct;64(10):1485-1495. doi: 10.1373/clinchem.2018.288746. Epub 2018 Aug 7.

PMID:
30087138
22.

Correlative Detection of Isolated Single and Multi-Cellular Calcifications in the Internal Elastic Lamina of Human Coronary Artery Samples.

Wen H, Morales Martinez A, Miao H, Larsen TC, Nguyen CP, Bennett EE, Moorse KP, Yu ZX, Remaley AT, Boehm M, Gharib AM.

Sci Rep. 2018 Jul 20;8(1):10978. doi: 10.1038/s41598-018-29379-6.

23.

Cardiovascular Benefits of Phenol-Enriched Virgin Olive Oils: New Insights from the Virgin Olive Oil and HDL Functionality (VOHF) Study.

Pedret A, Fernández-Castillejo S, Valls RM, Catalán Ú, Rubió L, Romeu M, Macià A, López de Las Hazas MC, Farràs M, Giralt M, Mosele JI, Martín-Peláez S, Remaley AT, Covas MI, Fitó M, Motilva MJ, Solà R.

Mol Nutr Food Res. 2018 Aug;62(16):e1800456. doi: 10.1002/mnfr.201800456. Epub 2018 Jul 30.

PMID:
29956886
24.

A thumbwheel mechanism for APOA1 activation of LCAT activity in HDL.

Cooke AL, Morris J, Melchior JT, Street SE, Jerome WG, Huang R, Herr AB, Smith LE, Segrest JP, Remaley AT, Shah AS, Thompson TB, Davidson WS.

J Lipid Res. 2018 Jul;59(7):1244-1255. doi: 10.1194/jlr.M085332. Epub 2018 May 17.

PMID:
29773713
25.

Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM.

Langlois MR, Chapman MJ, Cobbaert C, Mora S, Remaley AT, Ros E, Watts GF, Borén J, Baum H, Bruckert E, Catapano A, Descamps OS, von Eckardstein A, Kamstrup PR, Kolovou G, Kronenberg F, Langsted A, Pulkki K, Rifai N, Sypniewska G, Wiklund O, Nordestgaard BG; European Atherosclerosis Society (EAS) and the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Joint Consensus Initiative.

Clin Chem. 2018 Jul;64(7):1006-1033. doi: 10.1373/clinchem.2018.287037. Epub 2018 May 14.

PMID:
29760220
26.

Resolution of Lipoprotein Subclasses by Charge Detection Mass Spectrometry.

Lutomski CA, Gordon SM, Remaley AT, Jarrold MF.

Anal Chem. 2018 Jun 5;90(11):6353-6356. doi: 10.1021/acs.analchem.8b01127. Epub 2018 May 14.

PMID:
29756771
27.

Lipoprotein lipase regulates hematopoietic stem progenitor cell maintenance through DHA supply.

Liu C, Han T, Stachura DL, Wang H, Vaisman BL, Kim J, Klemke RL, Remaley AT, Rana TM, Traver D, Miller YI.

Nat Commun. 2018 Apr 3;9(1):1310. doi: 10.1038/s41467-018-03775-y.

28.

Structural properties of apolipoprotein A-I mimetic peptides that promote ABCA1-dependent cholesterol efflux.

Islam RM, Pourmousa M, Sviridov D, Gordon SM, Neufeld EB, Freeman LA, Perrin BS Jr, Pastor RW, Remaley AT.

Sci Rep. 2018 Feb 13;8(1):2956. doi: 10.1038/s41598-018-20965-2.

29.

Late-onset Cerebrotendinous Xanthomatosis with a Novel Mutation in the CYP27A1 Gene.

Sasamura A, Akazawa S, Haraguchi A, Horie I, Ando T, Abiru N, Takei H, Nittono H, Une M, Kurosawa T, Murai T, Naruse H, Nakayama T, Kotani K, Remaley AT, Kawakami A.

Intern Med. 2018 Jun 1;57(11):1611-1616. doi: 10.2169/internalmedicine.0120-17. Epub 2018 Feb 9.

30.

A comparison of three apolipoprotein B methods and their associations with incident coronary heart disease risk over a 12-year follow-up period: The Multi-Ethnic Study of Atherosclerosis.

Cao J, Steffen BT, Guan W, Remaley AT, McConnell JP, Palamalai V, Tsai MY.

J Clin Lipidol. 2018 Mar - Apr;12(2):300-304. doi: 10.1016/j.jacl.2017.12.013. Epub 2017 Dec 29.

PMID:
29370999
31.

NHLBI Working Group Recommendations to Reduce Lipoprotein(a)-Mediated Risk of Cardiovascular Disease and Aortic Stenosis.

Tsimikas S, Fazio S, Ferdinand KC, Ginsberg HN, Koschinsky ML, Marcovina SM, Moriarty PM, Rader DJ, Remaley AT, Reyes-Soffer G, Santos RD, Thanassoulis G, Witztum JL, Danthi S, Olive M, Liu L.

J Am Coll Cardiol. 2018 Jan 16;71(2):177-192. doi: 10.1016/j.jacc.2017.11.014. Review.

32.

Twelve Weeks of Medium-Intensity Exercise Therapy Affects the Lipoprotein Profile of Multiple Sclerosis Patients.

Jorissen W, Vanmierlo T, Wens I, Somers V, Van Wijmeersch B, Bogie JF, Remaley AT, Eijnde BO, Hendriks JJA.

Int J Mol Sci. 2018 Jan 8;19(1). pii: E193. doi: 10.3390/ijms19010193.

33.

Effects of Multiple Freeze/Thaw Cycles on Measurements of Potential Novel Biomarkers Associated With Adverse Pregnancy Outcomes.

Rebholz SL, Melchior JT, Welge JA, Remaley AT, Davidson WS, Woollett LA.

J Clin Lab Med. 2017;2(1). doi: 10.16966/2572-9578.107. Epub 2017 Feb 21.

34.

Nonalcoholic fatty liver disease in spinal and bulbar muscular atrophy.

Guber RD, Takyar V, Kokkinis A, Fox DA, Alao H, Kats I, Bakar D, Remaley AT, Hewitt SM, Kleiner DE, Liu CY, Hadigan C, Fischbeck KH, Rotman Y, Grunseich C.

Neurology. 2017 Dec 12;89(24):2481-2490. doi: 10.1212/WNL.0000000000004748. Epub 2017 Nov 15.

35.

Effect of Synthetic High Density Lipoproteins Modification with Polyethylene Glycol on Pharmacokinetics and Pharmacodynamics.

Li D, Fawaz MV, Morin EE, Ming R, Sviridov D, Tang J, Ackermann R, Olsen K, Remaley AT, Schwendeman A.

Mol Pharm. 2018 Jan 2;15(1):83-96. doi: 10.1021/acs.molpharmaceut.7b00734. Epub 2017 Nov 29.

36.

Apolipoprotein C-II: New findings related to genetics, biochemistry, and role in triglyceride metabolism.

Wolska A, Dunbar RL, Freeman LA, Ueda M, Amar MJ, Sviridov DO, Remaley AT.

Atherosclerosis. 2017 Dec;267:49-60. doi: 10.1016/j.atherosclerosis.2017.10.025. Epub 2017 Oct 20. Review.

37.

Determinants of HDL Cholesterol Efflux Capacity after Virgin Olive Oil Ingestion: Interrelationships with Fluidity of HDL Monolayer.

Fernández-Castillejo S, Rubió L, Hernáez Á, Catalán Ú, Pedret A, Valls RM, Mosele JI, Covas MI, Remaley AT, Castañer O, Motilva MJ, Solá R.

Mol Nutr Food Res. 2017 Dec;61(12). doi: 10.1002/mnfr.201700445. Epub 2017 Oct 26.

38.

Development of a novel fluorescent activity assay for lecithin:cholesterol acyltransferase.

Sakurai T, Sakurai A, Vaisman BL, Nishida T, Neufeld EB, Demosky SJ Jr, Sampson ML, Shamburek RD, Freeman LA, Remaley AT.

Ann Clin Biochem. 2018 Jul;55(4):414-421. doi: 10.1177/0004563217733285. Epub 2017 Nov 2.

PMID:
28882064
39.

Apolipoprotein B is associated with carotid atherosclerosis progression independent of individual cholesterol measures in a 9-year prospective study of Multi-Ethnic Study of Atherosclerosis participants.

Steffen BT, Guan W, Remaley AT, Stein JH, Tattersall MC, Kaufman J, Tsai MY.

J Clin Lipidol. 2017 Sep - Oct;11(5):1181-1191.e1. doi: 10.1016/j.jacl.2017.07.001. Epub 2017 Jul 12.

40.

High density lipoproteins and type 2 inflammatory biomarkers are negatively correlated in atopic asthmatics.

Barochia AV, Gordon EM, Kaler M, Cuento RA, Theard P, Figueroa DM, Yao X, Weir NA, Sampson ML, Stylianou M, Choy DF, Holweg CTJ, Remaley AT, Levine SJ.

J Lipid Res. 2017 Aug;58(8):1713-1721. doi: 10.1194/jlr.P077776. Epub 2017 Jun 27.

41.

Lecithin:Cholesterol Acyltransferase Activation by Sulfhydryl-Reactive Small Molecules: Role of Cysteine-31.

Freeman LA, Demosky SJ Jr, Konaklieva M, Kuskovsky R, Aponte A, Ossoli AF, Gordon SM, Koby RF, Manthei KA, Shen M, Vaisman BL, Shamburek RD, Jadhav A, Calabresi L, Gucek M, Tesmer JJG, Levine RL, Remaley AT.

J Pharmacol Exp Ther. 2017 Aug;362(2):306-318. doi: 10.1124/jpet.117.240457. Epub 2017 Jun 2.

42.

Apolipoprotein A-I Mimetic Peptides: Discordance Between In Vitro and In Vivo Properties-Brief Report.

Ditiatkovski M, Palsson J, Chin-Dusting J, Remaley AT, Sviridov D.

Arterioscler Thromb Vasc Biol. 2017 Jul;37(7):1301-1306. doi: 10.1161/ATVBAHA.117.309523. Epub 2017 May 18.

43.

Exenatide Improves HDL Particle Counts and Size Distribution in Patients With Long-standing Type 1 Diabetes.

Gourgari EA, Mete M, Sampson ML, Harlan DM, Remaley AT, Rother KI.

Diabetes Care. 2017 Jul;40(7):e88-e89. doi: 10.2337/dc16-2602. Epub 2017 May 17. No abstract available.

44.

Metreleptin therapy lowers plasma angiopoietin-like protein 3 in patients with generalized lipodystrophy.

Muniyappa R, Abel BS, Asthana A, Walter MF, Cochran EK, Remaley AT, Skarulis MC, Gorden P, Brown RJ.

J Clin Lipidol. 2017 Mar - Apr;11(2):543-550. doi: 10.1016/j.jacl.2017.02.002. Epub 2017 Feb 24.

45.

Dietary supplementation with long-chain monounsaturated fatty acid isomers decreases atherosclerosis and alters lipoprotein proteomes in LDLr-/- mice.

Yang ZH, Gordon SM, Sviridov D, Wang S, Danner RL, Pryor M, Vaisman B, Shichijo Y, Doisaki N, Remaley AT.

Atherosclerosis. 2017 Jul;262:31-38. doi: 10.1016/j.atherosclerosis.2017.04.017. Epub 2017 Apr 25.

PMID:
28486149
46.

Human Plasma Thioredoxin-80 Increases With Age and in ApoE-/- Mice Induces Inflammation, Angiogenesis, and Atherosclerosis.

Couchie D, Vaisman B, Abderrazak A, Mahmood DFD, Hamza MM, Canesi F, Diderot V, El Hadri K, Nègre-Salvayre A, Le Page A, Fulop T, Remaley AT, Rouis M.

Circulation. 2017 Aug 1;136(5):464-475. doi: 10.1161/CIRCULATIONAHA.117.027612. Epub 2017 May 4.

PMID:
28473446
47.

Cardiometabolic risk factors and health behaviors in family caregivers.

Ross A, Shamburek R, Wehrlen L, Klagholz SD, Yang L, Stoops E, Flynn SL, Remaley AT, Pacak K, Shelburne N, Bevans MF.

PLoS One. 2017 May 4;12(5):e0176408. doi: 10.1371/journal.pone.0176408. eCollection 2017.

48.

Human SR-BII mediates SAA uptake and contributes to SAA pro-inflammatory signaling in vitro and in vivo.

Baranova IN, Souza ACP, Bocharov AV, Vishnyakova TG, Hu X, Vaisman BL, Amar MJ, Chen Z, Remaley AT, Patterson AP, Yuen PST, Star RA, Eggerman TL.

PLoS One. 2017 Apr 19;12(4):e0175824. doi: 10.1371/journal.pone.0175824. eCollection 2017.

49.

Commentary.

Remaley AT.

Clin Chem. 2017 Mar;63(3):645. doi: 10.1373/clinchem.2016.263541. No abstract available.

50.

High density lipoproteins are modulators of protease activity: Implications in inflammation, complement activation, and atherothrombosis.

Gordon SM, Remaley AT.

Atherosclerosis. 2017 Apr;259:104-113. doi: 10.1016/j.atherosclerosis.2016.11.015. Epub 2016 Nov 16. Review.

Supplemental Content

Loading ...
Support Center